Termination Rights
The Purchase Agreement provides for customary termination rights for Purchaser and Seller including, among other things, (i) by mutual consent; (ii) if the Acquisition has not been consummated on or before August 3, 2026, subject to a 90-day extension under certain circumstances; (iii) by either Purchaser or Seller if there is a law or regulation making the Acquisition illegal or a final and non-appealable injunction or order permanently enjoining or prohibiting the consummation of the Acquisition; and (iv) by the Purchaser or Seller if Seller or Lanteris (in the case of termination by Purchaser) or Purchaser (in the case of termination by Seller) breaches its representations or fails to perform its covenants such that the conditions to closing fail to be satisfied (subject to a cure period).
Transitional Services Agreement
The Purchase Agreement contemplates that, at the closing of the Acquisition, Seller and Lanteris will enter into a Transitional Services Agreement, pursuant to which Seller has agreed to continue to provide or procure the provision of certain services, only on a transitional basis and in relation to specified business activities of Lanteris, for payment amounts set forth therein.
Lock-Up
The Purchase Agreement restricts the Seller from transferring 50% of the Stock Consideration for the first 180 days following the closing date of the Acquisition and from transferring the remaining 50% of the Stock Consideration for the first 365 days following the closing date of the Acquisition.
Registration Rights Agreement
The Purchase Agreement contemplates that, at the closing of the Acquisition, the Company and Seller will enter into a registration rights agreement (the “Registration Rights Agreement”), pursuant to which Seller will have certain registration rights, including the right to initiate up to three underwritten public offerings, and piggyback registration rights relating to the Stock Consideration.
The foregoing description of the Purchase Agreement and Registration Rights Agreement do not purport to be complete and are qualified in their entirety by the full text of the Purchase Agreement and Registration Rights Agreement, copies of which are filed as Exhibit 2.1 and 10.1 hereto, respectively, and are incorporated by reference herein.
The Purchase Agreement has been attached to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Company, the Purchaser, the Seller, Seller Parent or Lanteris. In particular, the assertions embodied in the representations and warranties contained in the Purchase Agreement are qualified by information in confidential disclosure schedules provided by each of the Company and the Purchaser, on the one hand, and the Seller, Seller Parent and Lanteris, on the other hand, to each other in connection with the signing of the Purchase Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations and warranties and certain covenants set forth in the Purchase Agreement. Moreover, the representations and warranties in the Purchase Agreement were used for the purposes of allocating risk between the parties rather than establishing matters of fact. Accordingly, the representations and warranties in the Purchase Agreement should not be relied on as characterization of the actual state of facts about the Company, the Purchaser, the Seller, Seller Parent or Lanteris.
| Item 2.02 |
Results of Operations and Financial Condition. |
On November 4, 2025, the Company issued a press release announcing certain financial results for the fiscal quarter ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information set forth under this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.